Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03304543
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
13S | 13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID | A | 1IK3 | 0.73 | |
6OB | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca- 8,12-dienoic acid | A,B | 2VV4 | 0.75 | |
E2P | PROSTAGLANDIN B2 | A | 1CZ2 | 0.71 | |
FA1 | 2,3 -ANHYDRO-QUINIC ACID | A | 1H0R | 0.7 | |
FA1 | 2,3 -ANHYDRO-QUINIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1GU1 | 0.7 | |
FA1 | 2,3 -ANHYDRO-QUINIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 2C57 | 0.7 | |
4HD | (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa- 5,7,10,13,16,19-hexaenoic acid | A,B | 2VV1 | 0.71 | |
SIM | SIMVASTATIN | A,B,C,D | 1HW9 | 0.7 | |
5HE | (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa- 6,8,11,14,17-pentaenoic acid | A,B | 2VV2 | 0.76 | |
243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 3DSJ | 0.75 | |
243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2RCH | 0.75 | |
243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2VST | 0.75 | |
LVA | (3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6- DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}- 1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN- 1-YL)-3,5-DIHYDROXYHEPTANOIC ACID | A,B | 1T02 | 0.72 | |
114 | COMPACTIN | A,B,C,D | 1HW8 | 0.72 | |
RCL | RICINOLEIC ACID | A | 2CM4 | 0.72 | |
RCL | RICINOLEIC ACID | A | 2CM9 | 0.72 | |
RCL | RICINOLEIC ACID | A | 1FK7 | 0.72 | |
MVB | (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO- 7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO- 4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]- 1-NAPHTHALENOL | A,B,C | 1YA8 | 0.7 | |
803 | LOVASTATIN | A,B | 1CQP | 0.72 | |
9HO | (9S,10E,12Z)-9-hydroxyoctadeca- 10,12-dienoic acid | A,B | 2VSR | 0.75 | |
9OH | (TRANS-12,13-EPOXY)-9-HYDROXY-10(E)- OCTADECENOIC ACID | A | 1IK3 | 0.72 | |
11O | (TRANS-12,13-EPOXY)-11-HYDROXY- 9(Z)-OCTADECENOIC ACID | A | 1IK3 | 0.72 | |
T24 | (9Z,11E,13S,15Z)-13-hydroxyoctadeca- 9,11,15-trienoic acid | A,B | 3DSI | 0.73 | |
164 | 2-(3-CARBOXYPROPIONYL)-6-HYDROXY- CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID | A | 1R6W | 0.71 | |
8PG | (8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID | A,B | 2G5W | 0.77 | |
PG2 | PROSTAGLANDIN D2 | A,B | 1RY0 | 0.84 | |
6OC | (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca- 9,12-dienoic acid | A,B | 2VV4 | 0.79 | |
PGX | 7-[6-(3-HYDROPEROXY-OCT-1-ENYL)- 2,3-DIOXA-BICYCLO[2.2.1]HEPT-5- YL]-HEPT-5-ENOIC ACID | A,B,C,D | 1DDX | 0.74 | |
OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec- 9-enoate | A | 3D4S | 0.71 | |
13R | 13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID | A | 1IK3 | 0.73 | |
EAH | (5S,7E,9E,11Z,14Z)-5-hydroxyicosa- 7,9,11,14-tetraenoic acid | A | 3DZT | 0.72 | |
DHK | 3-DEHYDROSHIKIMATE | A | 1WE2 | 0.71 | |
DHK | 3-DEHYDROSHIKIMATE | A,B | 1SFJ | 0.71 | |
DHK | 3-DEHYDROSHIKIMATE | A,B,C,D,E,F, G,H,I,J,K,L | 1GTZ | 0.71 | |
DHK | 3-DEHYDROSHIKIMATE | A | 2O7Q | 0.71 | |
DHK | 3-DEHYDROSHIKIMATE | A | 2O7S | 0.71 | |
5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A | 2ZB4 | 0.75 | |
5OP | (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA- 5,13-DIEN-1-OIC ACID | A,B | 1V3V | 0.75 | |
HO2 | (9E,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A | 3DBM | 0.75 | |
E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL- 4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2HFK | 0.78 |